Monthly visits during dose titration: weight check, side effect review, dose adjustment
The authors also emphasized that the wider use of these drugs should consider social and commercial determinants of health, including access, affordability and insurance coverage, to avoid deepening existing health inequities among people living with obesity
We encourage you to schedule a consultation to discuss whether peptide therapy might be a beneficial addition to your personalized treatment plan
Current 2024 multi-society guidance suggests most patients can continue GLP-1 agonist therapy with appropriate risk stratification rather than routine holds
These experimental systems aim to deliver the medication into systemic circulation without traditional injections
It disrupts physiological systems, including metabolism and immunity, increasing the likelihood of cardiovascular diseases and cancer [2]